<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01057485</url>
  </required_header>
  <id_info>
    <org_study_id>NAFAPAFv1.3</org_study_id>
    <nct_id>NCT01057485</nct_id>
  </id_info>
  <brief_title>Node and Atrial Fibrillation Ablation for Persistent Atrial Fibrillation</brief_title>
  <acronym>NAFAPAF</acronym>
  <official_title>Node and Atrial Fibrillation Ablation for Persistent Atrial Fibrillation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Eastbourne General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Eastbourne General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to assess combining AF ablation, with AV node ablation and
      pacemaker implantation for patients suffering with 'irregular heartbeats' or atrial
      fibrillation. The study will last 13 months.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>February 2010</start_date>
  <completion_date type="Anticipated">January 2012</completion_date>
  <primary_completion_date type="Anticipated">January 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To measure the two treatment effects on VO2 max over time by means of cardiopulmonary exercise testing.To measure the two treatment effects on 6-minute hall walk distance.Echocardiographic parameters</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Persistent Atrial Fibrillation</condition>
  <arm_group>
    <arm_group_label>AF ablation and AV node ablation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive the combined procedure of AF ablation as well as AV node ablation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>AV node ablation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patient will receive AV node ablation alone</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>AF ablation and AV node ablation</intervention_name>
    <description>AF ablation and AV node ablation</description>
    <arm_group_label>AF ablation and AV node ablation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>AV node ablation</intervention_name>
    <description>AV node ablation</description>
    <arm_group_label>AV node ablation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with symptomatic drug refractory atrial fibrillation.

          -  Patients who have had pacemaker implantation and AV node ablation with ongoing
             symptoms.

          -  Patients will already be refractory to at least 2 rate or rhythm control drugs.

          -  Patients must be over 18 years old.

          -  Patients give informed consent form prior to participating in this study.

        Exclusion Criteria:

          -  Patient is suffering with unstable angina in last 1 week.

          -  Patient has had a myocardial infarction within last 2 months.

          -  Patient is expecting or has had major cardiac surgery within last 2 months.

          -  Patient is participating in a conflicting study.

          -  Patient is unable to perform exercise testing.

          -  Patient is mentally incapacitated and cannot consent or comply with follow-up.

          -  Patient has NYHA class III/ IV heart failure.

          -  Patient has LVEF &lt;35% not secondary to tachycardia.

          -  Pregnancy.

          -  Patient suffers with other cardiac rhythm disorders.

          -  Recent coronary artery intervention or other factors suggesting clinical instability
             (ECG, clinical or laboratory findings).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Steven J Podd, MBBS, MA, MRCP</last_name>
    <phone>01323 417400</phone>
    <phone_ext>4132</phone_ext>
    <email>steven.podd@esht.nhs.uk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Eastbourne District General Hospital</name>
      <address>
        <city>Eastbourne</city>
        <state>East Sussex</state>
        <zip>BN21 2UD</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Steven J Podd, MBBS, MA, MRCP</last_name>
      <phone>01323 417400</phone>
      <phone_ext>4132</phone_ext>
      <email>stevenpodd@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>January 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 26, 2010</study_first_submitted>
  <study_first_submitted_qc>January 26, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 27, 2010</study_first_posted>
  <last_update_submitted>May 25, 2010</last_update_submitted>
  <last_update_submitted_qc>May 25, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 26, 2010</last_update_posted>
  <responsible_party>
    <name_title>Dr AN Sulke</name_title>
    <organization>NHS</organization>
  </responsible_party>
  <keyword>Atrial Fibrillation</keyword>
  <keyword>Ablation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

